1398-1399 / 2605
1
2
3
4
5
6
2
0
4
0
6
0
8
0
10
0
Years of follow-up
S
u
rv
iv
al
%
NIR
S
Elsewhere
Primary endpoint: overall survival
Sample size
HR: 1.5; Prob Event = 0.62
1:1 random assignment;
P(1-β) = 0.8; Pα = 0.05 (2-sided)
2 years follow-up
308 patients
Randomized trial : locally advanced pancreatic cancer